Lavipharm S.A. (ATH:LAVI)

Lavipharm Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	55.11	52.95	47.84	39.06	39.72	37.64
Revenue Growth (YoY)	19.49%	10.68%	22.48%	-1.68%	5.54%	12.06%
Cost of Revenue	30.74	27.87	25.69	21.44	23.84	21.42
Gross Profit	24.37	25.08	22.15	17.62	15.89	16.22
Selling, General & Admin	20.9	20.9	18.11	15.31	14.48	13.51
Research & Development	0.63	0.63	0.43	0.85	0.81	0.75
Other Operating Expenses	-2.18	-1.69	-1.11	-2.4	-4.91	-3.21
Operating Expenses	19.35	19.84	17.43	13.56	11.38	11.06
Operating Income	5.02	5.24	4.72	4.07	4.51	5.16
Interest Expense	-2.01	-2.01	-2.17	-0.72	-1.83	-1.92
Interest & Investment Income	0.15	0.15	0.27	0.03	0.02	0.03
Currency Exchange Gain (Loss)	0.02	0.02	0.05	-0.02	0	-0.01
Other Non Operating Income (Expenses)	-0.07	-0.07	-0.06	-0.92	-	-
EBT Excluding Unusual Items	3.11	3.33	2.81	2.44	2.7	3.26
Gain (Loss) on Sale of Investments	-0.24	-0.24	-0.48	-	-0.02	-0.02
Gain (Loss) on Sale of Assets	0.36	0.36	0.43	-	-	-
Asset Writedown	0.16	0.16	0.37	-	0.11	-
Other Unusual Items	-	-	0.09	-0.18	-0.05	0.07
Pretax Income	3.38	3.6	3.22	2.26	2.75	3.31
Income Tax Expense	1.32	-5.06	1.25	1.31	1.02	1.21
Earnings From Continuing Operations	2.06	8.66	1.97	0.95	1.73	2.1
Earnings From Discontinued Operations	1.21	0.32	-0.1	-0.12	-	-
Net Income to Company	3.27	8.98	1.87	0.83	1.73	2.1
Minority Interest in Earnings	0	0	0	0	-0.01	-0
Net Income	3.27	8.98	1.87	0.83	1.72	2.09
Net Income to Common	3.27	8.98	1.87	0.83	1.72	2.09
Net Income Growth	-63.61%	380.06%	124.34%	-51.60%	-17.72%	-60.69%
Shares Outstanding (Basic)	169	168	168	22	17	17
Shares Outstanding (Diluted)	169	168	168	22	17	17
Shares Change (YoY)	-	0.17%	681.40%	26.42%	-	-
EPS (Basic)	0.02	0.05	0.01	0.04	0.10	0.12
EPS (Diluted)	0.02	0.05	0.01	0.04	0.10	0.12
EPS Growth	-	379.94%	-71.35%	-61.71%	-17.72%	-60.69%
Free Cash Flow	-	-5	-3.77	-32.27	2.19	1.37
Free Cash Flow Per Share	-	-0.03	-0.02	-1.50	0.13	0.08
Dividend Per Share	-	0.020	-	-	-	-
Gross Margin	44.22%	47.37%	46.30%	45.12%	40.00%	43.10%
Operating Margin	9.11%	9.90%	9.86%	10.41%	11.35%	13.72%
Profit Margin	5.94%	16.96%	3.91%	2.14%	4.34%	5.56%
Free Cash Flow Margin	-	-9.45%	-7.87%	-82.63%	5.52%	3.65%
EBITDA	9.28	9.07	8.27	4.96	5.36	6.26
EBITDA Margin	16.84%	17.13%	17.30%	12.69%	13.48%	16.62%
D&A For EBITDA	4.26	3.83	3.56	0.89	0.85	1.09
EBIT	5.02	5.24	4.72	4.07	4.51	5.16
EBIT Margin	9.11%	9.90%	9.86%	10.41%	11.35%	13.72%
Effective Tax Rate	39.01%	-	38.78%	57.95%	37.09%	36.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.